FIRST DERIVATIVE SPECTROPHOTOMETRIC DETERMINATION OF FLUOXETINE HYDROCHLORIDE AND OLANZAPINE IN TABLETS

Fluoxetine hydrochloride (FH) in combination with Olanzapine (OZ) is used in treatment of depressive episodes associated with bipolar disorder. The first derivative spectrophotometric method for simultaneous determination of fluoxetine hydrochloride (FH) and olanzapine (OZ) from two component tablet dosage form has been developed and validated. Chromatographic methods viz. HPLC and HPTLC methods were reported in the literature for the simultaneous determination of FH and OZ from combined dosage forms. In the present investigation an attempt has been made to develop accurate, reproducible, rapid and cost-effective method for simultaneous determination of FH and OZ in pharmaceutical formulation. The wavelengths selected for determination of FH and OZ is 235.5nm and 296nm, respectively. The beer’s law was obeyed in the concentration range of 8-80μg/mL and 220μg/mL for Fluoxetine and Olanzapine, respectively. The proposed methods were validated and successfully applied to the determination of FH and OZ in tablet formulations. The results suggested that the proposed procedures can be used for routine quality control of tablets containing FH and OZ. INTRODUCTION: Fluoxetine hydrochloride (FH) in combination with Olanzapine (OZ) is used in treatment of depressive episodes associated with bipolar disorder . This combination of FH and OZ produce robust and sustained increases of extracellular levels of dopamine and norepinephrine, which were significantly greater than with either drug alone . This combination drugs are available in tablet dosage form in the market. The combination of FH and OZ is not official in any pharmacopoeia. The FH, a selective serotonin reuptake inhibitor, is chemically d, lNmethyl3phenyl-3-*α, α, αtrifluoroptolyl) oxy] propyl amine hydrochloride (Figure 1a). Chemically, olanzapine is 2-methyl-4-(4-methyl-1piperazinyl)-10H [2, 3-b] [1, 5] benzodiazepine (Figure 1b). FIG. 1A: FLUOXETINE HYDROCHLORIDE

[1]  S. Rajput,et al.  Development of a stability-indicating HPLC method for simultaneous determination of olanzapine and fluoxetine in combined dosage forms. , 2009, Journal of chromatographic science.

[2]  N. Patel,et al.  Simultaneous RP-HPLC and HPTLC Estimation of Fluoxetine Hydrochloride and Olanzapine in Tablet Dosage Forms , 2009, Indian journal of pharmaceutical sciences.

[3]  K. Basavaiah,et al.  Iodimetric assay of olanzapine in pharmaceuticals using iodate and Nile blue as reagents , 2009 .

[4]  N. Shah,et al.  Simultaneous assay of olanzapine and fluoxetine in tablets by column high-performance liquid chromatography and high-performance thin-layer chromatography. , 2007, Journal of AOAC International.

[5]  J. Sreeramulu,et al.  Simultaneous Determination of Olanzapine and Fluoxetine by HPLC , 2007 .

[6]  A. Krebs,et al.  Spectrophotometric Determination of Olanzapine by Its Oxidation with N-Bromosuccinimide and Cerium(IV)sulfate , 2006, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.

[7]  A. Jasińska,et al.  Batch and flow-injection methods for the spectrophotometric determination of olanzapine , 2004 .

[8]  J. Calabrese,et al.  Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. , 2003, Archives of general psychiatry.

[9]  N. Erk,et al.  Voltammetric, Spectrophotometric, and High Performance Liquid Chromatographic Analysis of Olanzapine , 2003 .

[10]  M. Mabrouk,et al.  Liquid chromatographic determination of fluoxetine. , 2002, Journal of pharmaceutical and biomedical analysis.

[11]  A. Alañon,et al.  Cyclodextrin enhanced spectrofluorimetric determination of fluoxetine in pharmaceuticals and biological fluids. , 2002, Talanta.

[12]  M. Raggi,et al.  Rapid methods for determination of fluoxetine in pharmaceutical formulations. , 2002, Journal of pharmaceutical and biomedical analysis.

[13]  E. Kenndler,et al.  Quantitation of olanzapine in tablets by HPLC, CZE, derivative spectrometry and linear voltammetry. , 2000, Journal of pharmaceutical and biomedical analysis.

[14]  D. Wong,et al.  Synergistic Effects of Olanzapine and Other Antipsychotic Agents in Combination with Fluoxetine on Norepinephrine and Dopamine Release in Rat Prefrontal Cortex , 2000, Neuropsychopharmacology.

[15]  J. Nevado,et al.  Method development and validation for the simultaneous determination of fluoxetine and fluvoxamine in pharmaceutical preparations by capillary electrophoresis , 2000 .

[16]  J. J. Berzas Nevado,et al.  Determination of fluoxetine, fluvoxamine, and clomipramine in pharmaceutical formulations by capillary gas chromatography. , 2000, Journal of chromatographic science.

[17]  R. Giridhar,et al.  Spectrophotometric determination of fluoxetine hydrochloride in bulk and in pharmaceutical formulations. , 1999, Journal of pharmaceutical and biomedical analysis.

[18]  J. Lima,et al.  Electrochemical studies and square wave adsorptive stripping voltammetry of the antidepressant fluoxetine. , 1999, Talanta.

[19]  M. Naik,et al.  Extractive Spectrophotometric Estimation Of Fluoxetine Hydrochloride In Pharmaceutical Formulations , 1999 .